368 related articles for article (PubMed ID: 36395147)
1. Infectious origin of Alzheimer's disease: Amyloid beta as a component of brain antimicrobial immunity.
Vojtechova I; Machacek T; Kristofikova Z; Stuchlik A; Petrasek T
PLoS Pathog; 2022 Nov; 18(11):e1010929. PubMed ID: 36395147
[TBL] [Abstract][Full Text] [Related]
2. The antimicrobial protection hypothesis of Alzheimer's disease.
Moir RD; Lathe R; Tanzi RE
Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
4. The Use of Antimicrobial and Antiviral Drugs in Alzheimer's Disease.
Iqbal UH; Zeng E; Pasinetti GM
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664669
[TBL] [Abstract][Full Text] [Related]
5. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
Castello MA; Soriano S
Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
7. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
Cho JE; Kim JR
Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
[TBL] [Abstract][Full Text] [Related]
8. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
9. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
10. Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.
Conway KA; Baxter EW; Felsenstein KM; Reitz AB
Curr Pharm Des; 2003; 9(6):427-47. PubMed ID: 12570807
[TBL] [Abstract][Full Text] [Related]
11. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
[TBL] [Abstract][Full Text] [Related]
12. The role of G protein-coupled receptors in the pathology of Alzheimer's disease.
Thathiah A; De Strooper B
Nat Rev Neurosci; 2011 Feb; 12(2):73-87. PubMed ID: 21248787
[TBL] [Abstract][Full Text] [Related]
13. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
Barage SH; Sonawane KD
Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
[TBL] [Abstract][Full Text] [Related]
14. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
Dunys J; Valverde A; Checler F
J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
[TBL] [Abstract][Full Text] [Related]
15. The many faces of amyloid beta in Alzheimer's disease.
Chiang PK; Lam MA; Luo Y
Curr Mol Med; 2008 Sep; 8(6):580-4. PubMed ID: 18781964
[TBL] [Abstract][Full Text] [Related]
16. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
17. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.
Suh YH; Checler F
Pharmacol Rev; 2002 Sep; 54(3):469-525. PubMed ID: 12223532
[TBL] [Abstract][Full Text] [Related]
18. Multi-pathogen infections and Alzheimer's disease.
Vigasova D; Nemergut M; Liskova B; Damborsky J
Microb Cell Fact; 2021 Jan; 20(1):25. PubMed ID: 33509204
[TBL] [Abstract][Full Text] [Related]
19. The Beneficial Role of Exercise on Treating Alzheimer's Disease by Inhibiting β-Amyloid Peptide.
Tan ZX; Dong F; Wu LY; Feng YS; Zhang F
Mol Neurobiol; 2021 Nov; 58(11):5890-5906. PubMed ID: 34415486
[TBL] [Abstract][Full Text] [Related]
20. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
